Volume 9, Issue 3, Pages 245-253 (March 2010) Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial  Ivo N van Schaik, MD, Filip Eftimov, MD, Pieter A van Doorn, MD, Esther Brusse, MD, Leonard H van den Berg, MD, W Ludo van der Pol, MD, Catharina G Faber, MD, Joost CH van Oostrom, MD, Oscar JM Vogels, MD, Rob DM Hadden, MD, Bert U Kleine, MD, Anouk GW van Norden, MD, Jan JGM Verschuuren, MD, Marcel GW Dijkgraaf, PhD, Marinus Vermeulen, MD  The Lancet Neurology  Volume 9, Issue 3, Pages 245-253 (March 2010) DOI: 10.1016/S1474-4422(10)70021-1 Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile *1 stopped after first cycle of dexamethasone because of glaucoma, 10 reached an endpoint. †7 reached an endpoint. The Lancet Neurology 2010 9, 245-253DOI: (10.1016/S1474-4422(10)70021-1) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 2 Remission at 12 months Odds ratio for proportion of patients who deteriorated 2·43 (95% CI 0·7–9·1). The Lancet Neurology 2010 9, 245-253DOI: (10.1016/S1474-4422(10)70021-1) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 3 Time to reach remission The Lancet Neurology 2010 9, 245-253DOI: (10.1016/S1474-4422(10)70021-1) Copyright © 2010 Elsevier Ltd Terms and Conditions